StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
TBPHTheravance Biopharma, Inc.
stockpulse.co.kr
Nasdaq
$17.03▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $882.6MShares out 51.8M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

40
  • 10.5After-hours26.10.06 05:05
    15-12GOther#●●●

    Theravance Biopharma, Inc.

    Theravance Biopharma has filed Form 15-12G to terminate the registration of its ordinary shares under the Securities Exchange Act and suspend its duty to file periodic reports. The company reported that the number of record holders for its shares is currently one.…more

    $17.03+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.28Regular26.09.29 04:20
    4Ownership

    Theravance Biopharma, Inc.

    Weiss Asset Management LP and its affiliates filed a Form 4 regarding changes in their beneficial ownership of Theravance Biopharma, Inc. securities. The filing reports internal equity transactions that occurred on September 23, 2026.…more

    $17.03+0.00%vs prev close
    View filingShare
  • 9.25After-hours26.09.26 05:01
    SCHEDULE 13D/AOwnership

    Theravance Biopharma, Inc.

    Weiss Asset Management LP has filed a SCHEDULE 13D/A regarding its beneficial ownership in Theravance Biopharma, Inc. This filing serves as an update to the reporting entity's significant equity position in the company.…more

    $17.03+0.00%vs prev close
    View filingShare

39 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.